Coinfection between Pulmonary Tuberculosis and Systemic Lupus Erythematosus: A 20-year Bibliometric Study
John Barja-Ore1, Alexandra Liñan-Bermudez2, Brandon E Guillen-Calle3
1Academic Department, Universidad Privada Del Norte, Lima, Peru.
Background:
Pulmonary tuberculosis (PTB) has a major global impact and has been reported as one of the most relevant complications in patients with systemic lupus erythematosus (SLE). The aim of this study was to analyze the bibliometric parameters of the scientific literature indexed in Scopus regarding the coinfection between PTB and SLE.
Methods:
A bibliometric study was conducted using a search strategy with MeSH terms to identify articles indexed in Scopus. After screening, 122 articles were included in the study. Bibliometric tools (SciVal, VOSviewer, and Bibliometrix) were used to analyze publication metadata.
Results:
Scientific production showed an annual growth rate of 4.56%, with a mean of 22.4 citations per publication per year. Rheumatology International, ranked in Q2, was the most relevant journal in the field of PTB and SLE, followed by Clinical Rheumatology and the Indian Journal of Tuberculosis. India demonstrated the greatest growth, with approximately 125 articles, whereas Brazil ranked fifth with sustained productivity. National collaboration was most frequent (46.7%); however, articles with international authorship achieved greater impact, with 209.8 citations per publication and 148% more citations than expected.
Conclusion:
Scientific output on PTB and SLE has steadily increased over the past 20 years. India, China, and Brazil lead the field, with international cooperation playing an emerging but significant role. The main publication venues are journals ranked in Q2 and Q3.
More Related Videos
23:06The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
09:02An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
Related Concept Videos
01:28Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:31Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...